Table 2

Person trade-off (PTO) results in stages of elicitation process in panel sessions (n = 229).

Change in PTO numbers (in thousand) in panel sessions
 Distribution of final PTO numbers (%)
 Difference in
distribution of final PTO numbers across countries (Chi-squared test)
 Difference in
distribution of final PTO numbers across health care professional status (Chi-squared test)

Disease stages
 Difference between initial PTO and PTO after panel discussion
 Difference between
PTO after panel discussion and final PTO (consistency checks)
 <100
 = 100
 >100

Quadriplegia (anchoring state)†
 44
 44
 25
 17
 58
 <0.0001
 ns
Severe depression
 307**
 -2
 14
 9
 77
 <0.0001
 ns
Severe asthma
 529***
 -4
 0
 0.5
 99.5
 ns
 ns
Stroke (moderate permanent impairments)
 198
 0.9
 2
 3
 95
 <0.05
 ns
Vision disorder (mild/moderate)
 -44
 44
 1
 0.5
 98.5
 ns
 ns
Chronic low back pain
 436***
 65
 0.5
 1
 98.5
 ns
 ns
Severe stable angina (NYHA3)
 224*
 44
 0
 1
 99
 ns
 ns
Breast cancer (disease-free stage without sequelae)
 76
 126
 0
 1
 99
 ns
 ns
Uncomplicated diabetes
 144*
 39
 0
 0.5
 99.5
 ns
 ns

† PTO reference programme was the prevention of 100 rapidly fatal disease cases in quadriplegia, and 100 cases of quadriplegia in other disease stages * p < 0.05, ** p < 0.01, *** p < 0.001 in paired t-test.

Schwarzinger et al. Population Health Metrics 2003 1:9   doi:10.1186/1478-7954-1-9